全文获取类型
收费全文 | 1341篇 |
免费 | 20篇 |
专业分类
电工技术 | 6篇 |
综合类 | 1篇 |
化学工业 | 69篇 |
金属工艺 | 1篇 |
机械仪表 | 12篇 |
建筑科学 | 19篇 |
矿业工程 | 1篇 |
能源动力 | 5篇 |
轻工业 | 43篇 |
水利工程 | 1篇 |
无线电 | 80篇 |
一般工业技术 | 73篇 |
冶金工业 | 966篇 |
原子能技术 | 7篇 |
自动化技术 | 77篇 |
出版年
2022年 | 4篇 |
2021年 | 4篇 |
2020年 | 6篇 |
2019年 | 5篇 |
2018年 | 9篇 |
2017年 | 6篇 |
2016年 | 13篇 |
2015年 | 15篇 |
2014年 | 13篇 |
2013年 | 17篇 |
2012年 | 16篇 |
2011年 | 20篇 |
2010年 | 26篇 |
2009年 | 29篇 |
2008年 | 19篇 |
2007年 | 22篇 |
2006年 | 21篇 |
2005年 | 17篇 |
2004年 | 21篇 |
2003年 | 19篇 |
2002年 | 19篇 |
2001年 | 7篇 |
2000年 | 9篇 |
1999年 | 33篇 |
1998年 | 273篇 |
1997年 | 153篇 |
1996年 | 111篇 |
1995年 | 60篇 |
1994年 | 67篇 |
1993年 | 67篇 |
1992年 | 23篇 |
1991年 | 12篇 |
1990年 | 15篇 |
1989年 | 19篇 |
1988年 | 14篇 |
1987年 | 17篇 |
1986年 | 17篇 |
1985年 | 12篇 |
1983年 | 2篇 |
1982年 | 5篇 |
1981年 | 5篇 |
1980年 | 10篇 |
1979年 | 3篇 |
1978年 | 5篇 |
1977年 | 19篇 |
1976年 | 68篇 |
1975年 | 2篇 |
1973年 | 2篇 |
1972年 | 2篇 |
1967年 | 2篇 |
排序方式: 共有1361条查询结果,搜索用时 14 毫秒
991.
992.
P. Franzen H. Falter B. Heinemann Ch. Martens U. Fantz M. Berger S. Christ-Koch M. Fröschle D. Holtum W. Kraus S. Leyer P. McNeely R. Riedl R. Süss S. Obermayer E. Speth D. Wünderlich 《Fusion Engineering and Design》2007,82(4):407-423
IPP Garching is currently developing a negative hydrogen ion RF source for the ITER neutral beam system. The source demonstrated already current densities in excess of the ITER requirements (>200 A/m2 D−) at the required source pressure and electron/ion ratio, but with only small extraction area and limited pulse length. A new test facility (RADI) went recently into operation for the demonstration of the required (plasma) homogeneity of a large RF source and the modular driver concept.The source with the dimension of 0.8 m × 0.76 m has roughly the width and half the height of the ITER source; its modular driver concept will allow an easy extrapolation in only one direction to the full size ITER source. The RF power supply consists of two 180 kW, 1 MHz RF generators capable of 30 s pulses. A dummy grid matches the conductance of the ITER source. Full size extraction is presently not possible due to the lack of an insulator, a large size extraction system and a beam dump.The main parameters determining the performance of this “half-size” source are the negative ion and electron density in front of the grid as well as the homogeneity of their profiles across the grid. Those will be measured by optical emission and cavity ring down spectroscopy, by Langmuir probes and laser detachment. These methods have been calibrated to the extracted current densities achieved at the smaller source test facilities at IPP for similar source parameters. However, in order to get some information about the possible ion and electron currents, local single aperture extraction with a Faraday cup system is planned. 相似文献
993.
Shorter clotting times were found in the presence of 50 mM Hepes (N-2-hydroxyethylpiperazine-N1-2-ethanesulfonic acid) buffer than of 50mM Imidazole buffer in one-stage assays of factors V and VIII, in modified APTT and PT tests and in tests of the clotting of human plasma by purified human thrombin. All tests were performed at ionic strength 0.155 in the presence of either Hepes. NaOH or Imidazole. HCl buffer, pH 7.4 at 37 degrees. The faster clotting in the presence of Hepes buffer, therefore, is probably due, at least in part, to acceleration by Hepes of thrombin's enzymatic action on fibrinogen and/or of the polymerization of the fibrin monomers. Hepes may also have effects of other blood clotting reactions. Rates of hydrolysis of TAME or BAME (p-toluenesulfonyl- or benzoyl-L-arginine methyl ester) at pH 7.4 37 degrees by purified human bovine thrombin were essentially the same in 200 mM Hepes as in 250 mM Tris. HCl buffer (rates in Hepes. NaOH or Hepes. KOH buffers were compared with those in Tris. HCl plus NaCl for KCl). However, with purified bovine thrombokinase, rates of TAME hydrolysis in Hepes buffer were accelerated and rates of BAME hydrolysis slightly inhibited. Hepes, therefore, reacts with thrombokinase but whether this accelerates (or inhibits) the rate of converting prothrombin to thrombin remains to be determined. In addition, Hepes has an inhibitory effect on clotting since increasing the concentration of Hepes from 50 mM to 200 mM inhibits clotting in the PT, APTT and bovine thrombin-human plasma tests. Hepes buffer is being added to some plasmas and to some reagents used in clotting tests. It is, therefore, important to realize that its concentration must be monitored closely or erroneous results may be obtained in clotting tests and assays of clotting factors. The clotting times were the same in the presence of 50 mM Tris. HCl as in Imidazole. HCl buffers in APTT tests at three ionic strengths but they differed slightly in plasma-thrombin tests. Depending upon the ionic strength, 17 mM Barbital Sodium. HCl buffer inhibited APTT tests but accelerated plasma-thrombin tests. All the buffers tested, therefore, have individual effects on the clotting tests. 相似文献
994.
995.
996.
997.
BE Scanley MS al-Tikriti MS Gandelman M Laruelle Y Zea-Ponce RM Baldwin SS Zoghbi PB Hoffer DS Charney S Wang 《Canadian Metallurgical Quarterly》1995,22(1):4-11
The aim of our randomized controlled study was to compare the neuromuscular characteristics of mivacurium and atracurium by evaluating the intubation conditions, intubation times, onset times and the duration of action of these two muscle relaxants using two different dosing principles. Forty-eight patients were included in this study. All patients were premedicated orally with 0.2 mg/kg diazepam. Anaesthesia was induced with 2.0 mg/kg propofol and 0.02 mg/kg alfentanil and maintained with 6 mg/kg/h propofol and 60% nitrous oxide in oxygen. Neuromuscular monitoring was carried out with supramaximal TOF-stimulation (2 HZ) of the ulnar nerve every 10 seconds and recording of the mechanomyogram (MMG) (Myograph 2000, Biometer) at the adductor pollicis muscle. The patients of group 1 (n = 12) received an intubation dose of 0.15 mg/kg mivacurium (2 x ED95) and the patients of group 2 (n = 12) received a priming dose of 0.015 mg/kg mivacurium (20% of ED95) followed by an intubation dose of only 0.07 mg/kg mivacurium (ED95) two minutes later. The patients of group 3 (n = 12) were intubated with 0.46 mg/kg atracurium (2 x ED95) and the patients of group 4 (n = 12) received a priming dose of 0.046 mg/kg atracurium (20% of ED95) and an intubation dose of 0.23 mg/kg atracurium (ED95) four minutes later. The patients were intubated under normocapnic conditions and following stabilisation of the palmar skin temperature after a 90% neuromuscular block (T1) had occurred. The intubation conditions were measured semiquantitatively using an intubation score.(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献
998.
999.
1000.